DR DAVID TAN



Consultant, Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS)
Assistant Professor, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore (NUS)
Associate Chairman Medical Board (Research), National University Hospital (NUH)
Head, Innovation Transfer Office (Research Office), National University Health System (NUHS)

Dr David Tan is a consultant medical oncologist and clinician scientist at the National University Cancer Institute, Singapore. His primary clinical and research interests are in gynaecological (ovarian, endometrial and cervical) cancers and the development of novel anti-cancer therapeutic agents.

Dr Tan graduated with a BSc in Experimental Pathology (1st Class Honours) and MBBS with Distinction from Guy’s, King’s and St Thomas’ School of Medicine, University of London, UK. He undertook training in internal medicine at Hammersmith Hospital and Guy’s and St Thomas’ Hospitals in London, and obtained his MRCP(UK) in 2005. In that same year, he was awarded a Cancer Research UK (CRUK) Clinical Research Fellowship at The Institute of Cancer Research (the academic partner institution of The Royal Marsden Hospital), London, where he did research in ovarian and breast cancers and obtained his PhD in Oncology. He subsequently completed his specialist training in Medical Oncology at The Royal Marsden Hospital, London. After working in the Drug Development Unit at The Royal Marsden Hospital/ Institute of Cancer Research, he went on to complete another fellowship at the Princess Margaret Cancer Centre, University of Toronto, Canada, in Drug Development and Gynaecologic Oncology before returning back to Singapore.

In addition to his clinical and academic duties, he is currently also the Associate Chairman Medical Board for Research at the National University Hospital, Singapore and Head of the Innovation Transfer Office at National University Health Systems (NUHS). He is also a member of the Novel Agents Committee for Cancer (NACC) at the Experimental Therapeutics Centre in A*STAR Singapore.

Education and Fellowships
• BSc(Hons)(London), MBBS(Distinction)(London), PG Dip(Oncology), MRCP(UK)(Medical Oncology), PhD(London)
• 2005-2008: Cancer Research UK Clinical Research Fellowship, The Institute of Cancer Research, London, UK – PhD
• 2008-2012: The Royal Marsden Hospital Medical Oncology Training Rotation, London, UK – Certificate of Completion of Training (CCT) in Medical Oncology and MRCP(UK)(Medical Oncology)
• 2012-2013: Fellowship in Gynaecologic Oncology and Drug Development, Princess Margaret Cancer Centre, University of Toronto, Canada

Awards and Honours
• 1996 1st Year Distinction in Basic Medical Sciences, Guy’s & St Thomas’ Hospitals Medical School, University of London
• 1998 BSc Prize for Experimental Pathology, Guy’s & St Thomas’ Hospitals Medical School, University of London
• 1999 3rd Year Merit Award, Guy’s King’s & St Thomas’ School of Medicine, University of London
• 2000 4th Year Merit Award, Guy’s King’s & St Thomas’ School of Medicine, University of London
• 2001 5th Year Merit Award, Guy’s King’s & St Thomas’ School of Medicine, University of London
• 2001 MBBS with Distinction, Guy’s King’s & St Thomas’ School of Medicine, University of London
• 2005 Cancer Research UK Clinical Research Fellowship Award
• 2007 Sir Alastair Currie Prize (Best Scientific Poster Presentation, 4th Meeting of the British Division of the IAP and the Pathological Society of Great Britain and Ireland)
• 2008 Young Investigator Award (5th European Congress: Perspectives in Gynaecologic Oncology, Cannes, France)
• 2011 Travelling Fellowship Award for the Helene Harris Memorial Trust 12th International Forum on Ovarian Cancer, Miami, Florida
• 2012 AACR-ECCO-ASCO Fellowship for FLIMS 14 Workshop on Methods in Clinical Cancer Research
• 2013 Singapore National Medical Research Council (NMRC) Transition Award
• 2014 European Society of Medical Oncology Travel Grant Award

Professional Memberships
• American Society of Clinical Oncology
• The Royal College of Physicians, London, UK
• European Society of Medical Oncology

Specialty Interests
• Gynaecologic Cancer
• Drug Development/ Phase I trials

Lear More about DR DAVID TAN!